In 3-day marathon, ODAC winnows “dangling” accelerated approvals of PD-1/PD-L1 drugs

This was not your ordinary ODAC, but a three-day checkpoint inhibitor marathon that consumed April 27, 28, and 29. You might call it six ODACs for the price of one: subtle as all get-out, if-you-blink-you-miss-it head-spinner of a shindig.